Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008633
Filing Date
2019-05-15
Accepted
2019-05-14 18:16:52
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_relmadatherapeutics.htm 10-Q 421767
2 CERTIFICATE OF AMENDMENT TO RELMADA THERAPEUTICS, INC. ARTICLES OF INCORPORATION f10q0319ex3-1_relmada.htm EX-3.1 658
3 FORM OF WARRANT f10q0319ex4-1_relmada.htm EX-4.1 69494
4 AMENDMENT NO. 4 TO THE RELMADA THERAPEUTICS, INC. 2014 STOCK OPTION AND EQUITY I f10q0319ex10-1_relmada.htm EX-10.1 9555
5 FORM OF UNIT PURCHASE AGREEMENT f10q0319ex10-2_relmada.htm EX-10.2 235846
6 FORM OF SUBSCRIPTION AGREEMENT f10q0319ex10-3_relmada.htm EX-10.3 186917
7 FORM OF REGISTRATION RIGHTS AGREEMENT f10q0319ex10-4_relmada.htm EX-10.4 130678
8 CERTIFICATION f10q0319ex31-1_relmada.htm EX-31.1 11694
9 CERTIFICATION f10q0319ex31-2_relmada.htm EX-31.2 12054
10 CERTIFICATION f10q0319ex32-1_relmada.htm EX-32.1 5136
11 CERTIFICATION f10q0319ex32-2_relmada.htm EX-32.2 4878
12 GRAPHIC ex3-1_001.jpg GRAPHIC 1031530
  Complete submission text file 0001213900-19-008633.txt   5181810

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE rlmd-20190331.xml EX-101.INS 452691
14 XBRL SCHEMA FILE rlmd-20190331.xsd EX-101.SCH 47130
15 XBRL CALCULATION FILE rlmd-20190331_cal.xml EX-101.CAL 44594
16 XBRL DEFINITION FILE rlmd-20190331_def.xml EX-101.DEF 195012
17 XBRL LABEL FILE rlmd-20190331_lab.xml EX-101.LAB 347081
18 XBRL PRESENTATION FILE rlmd-20190331_pre.xml EX-101.PRE 261120
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55347 | Film No.: 19824304
SIC: 2834 Pharmaceutical Preparations